Athenex, Inc. is a company in the U.S. stock market and it is a holding in 31 U.S.-traded ETFs. ATNX has around 5.3M shares in the U.S. ETF market. The largest ETF holder of ATNX is the iShares Russell 2000 ETF (IWM), with approximately 1.60M shares. Investors may also find of interest that the ETF with the largest allocation to ATNX stock is Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a portfolio weight of 0.75%. On average, U.S. ETFs allocate 0.12% of ATNX to their portfolios.
Additionally, ATNX is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ATNX as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 35.39%.